- Trials with a EudraCT protocol (686)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
686 result(s) found for: Z Drug.
Displaying page 1 of 35.
EudraCT Number: 2009-017649-67 | Sponsor Protocol Number: nnisbjl2009 | Start Date*: 2010-06-22 |
Sponsor Name:The Central Remedial Clinic and The Children's University Hospital | ||
Full Title: Bone Health in Duchenne Muscular Dystrophy- a case controlled study of Risedronate use | ||
Medical condition: Bone Health in Duchenne Muscular Dystrophy- a randomised controlled study of Risedronate use | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003365-99 | Sponsor Protocol Number: NL62809.068.17 | Start Date*: 2017-11-08 |
Sponsor Name:Maastricht University | ||
Full Title: The effects of ceasing opioid, benzodiazepine, or Z-hypnotic drug use on measures of driving performance and postural balance. | ||
Medical condition: Insomnia, Anxiety, chronic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000735-14 | Sponsor Protocol Number: L-A/2017/COM/01 | Start Date*: 2018-01-19 |
Sponsor Name:Lek-Am Sp. z o.o. | ||
Full Title: The efficacy and safety of new formulation of combination of fluticasone propionate / salmeterol (125μg / 25μg) in MDI HFA inhaler compared with the reference drug at a dose of 500μg / 50μg in DPI... | ||
Medical condition: Asthma is a common, chronic respiratory disease affecting 1–18% of the population in different countries. Asthma is characterized by variable symptoms of wheeze, shortness of breath, chest tightnes... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004128-39 | Sponsor Protocol Number: C25006 | Start Date*: 2013-07-08 | |||||||||||
Sponsor Name:Millennium Pharmaceuticals, Inc | |||||||||||||
Full Title: A Phase 4, Open–label, Single-Arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma | |||||||||||||
Medical condition: Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Ongoing) BE (Ongoing) PT (Ongoing) ES (Ongoing) PL (Ongoing) HU (Completed) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003083-39 | Sponsor Protocol Number: 20140444 | Start Date*: 2017-01-09 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis | |||||||||||||
Medical condition: Glucocorticoid-induced Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) BG (Prematurely Ended) Outside EU/EEA IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000184-40 | Sponsor Protocol Number: 20130173 | Start Date*: 2014-09-11 | |||||||||||
Sponsor Name:Amgen, Inc. | |||||||||||||
Full Title: Prospective, Multicenter, Single-arm Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Denosumab in Children With Osteogenesis Imperfecta | |||||||||||||
Medical condition: Osteogenesis Imperfecta | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) GB (GB - no longer in EU/EEA) HU (Completed) ES (Completed) Outside EU/EEA BG (Completed) PL (Prematurely Ended) BE (Completed) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004827-29 | Sponsor Protocol Number: VX14-661-110 | Start Date*: 2015-09-01 | |||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | |||||||||||||
Full Title: A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long term Treatment With VX 661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, ... | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) IE (Completed) GB (GB - no longer in EU/EEA) BE (Completed) SE (Completed) AT (Completed) FR (Completed) DK (Completed) NL (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001552-19 | Sponsor Protocol Number: TOPMATEPY4067 | Start Date*: 2014-12-16 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Randomized, Active-Controlled, Open-Label, Flexible-Dose Study to Assess the Safety and Tolerability of Topiramate as Monotherapy Compared with Levetiracetam as Monotherapy in Pediatric Subjects ... | |||||||||||||
Medical condition: New-onset or recent-onset epilepsy. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) IT (Completed) HU (Completed) BE (Completed) DE (Completed) GB (Completed) FR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023589-39 | Sponsor Protocol Number: ST10-01-302 | Start Date*: 2012-04-10 | ||||||||||||||||
Sponsor Name:Iron Therapeutics (Switzerland) AG | ||||||||||||||||||
Full Title: A prospective, multicentre, randomised, double-blind, placebo controlled study with oral ST10-021 for the treatment of iron deficiency anaemia in subjects with quiescent Crohn's Disease where oral ... | ||||||||||||||||||
Medical condition: Iron deficiency anaemia in quiescent Crohn's Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) GB (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023588-16 | Sponsor Protocol Number: ST10-01-301 | Start Date*: 2012-04-10 | ||||||||||||||||
Sponsor Name:Iron Therapeutics (Switzerland) AG | ||||||||||||||||||
Full Title: A prospective, multicentre, randomised, double-blind, placebo controlled study with oral ST10-021 for the treatment of iron deficiency anaemia in subjects with quiescent ulcerative colitis where or... | ||||||||||||||||||
Medical condition: Iron deficiency anaemia in quiescent ulcerative colitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) AT (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004433-17 | Sponsor Protocol Number: 124210 | Start Date*: 2020-02-18 | |||||||||||
Sponsor Name:MRC CTU at UCL | |||||||||||||
Full Title: Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary arte... | |||||||||||||
Medical condition: Kawasaki Disease | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Ongoing) EE (Ongoing) SE (Ongoing) FI (Ongoing) ES (Ongoing) DE (Ongoing) NL (Ongoing) IT (Ongoing) AT (Ongoing) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002496-26 | Sponsor Protocol Number: ST10-01-304 | Start Date*: 2015-12-02 | ||||||||||||||||
Sponsor Name:Shield TX (UK) Ltd. | ||||||||||||||||||
Full Title: A phase 3b, randomized, controlled, multicentre study with oral ferric maltol (Feraccru) or intravenous iron (ferric carboxymaltose; FCM), for the treatment of iron deficiency anaemia in subjects w... | ||||||||||||||||||
Medical condition: Iron deficiency anaemia with inflammatory bowel disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) BE (Completed) ES (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001157-97 | Sponsor Protocol Number: D9614C00099 | Start Date*: 2012-03-08 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Randomized, Open-Label Study to Evaluate the Pharmacokinetics of Multiple Doses of Esomeprazole Magnesium in a Pediatric Population of 1 to 11 Year olds with Gastroesophageal Reflux Disease (GERD... | |||||||||||||
Medical condition: The target subject population was male and female children, aged 1 to 11 years inclusive, who suffered from GERD or symptoms of GERD and were candidates for acid suppression therapy. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013803-70 | Sponsor Protocol Number: 01/2009 | Start Date*: 2009-12-28 |
Sponsor Name:Splošna bolnišnica Celje | ||
Full Title: Modified PCA regimen of remifentanil delivery for labour pain Prilagojeno od porodnice vodeno lajšanje porodne bolečine z remifentanilom | ||
Medical condition: pregnancy, labour, labour pain | ||
Disease: | ||
Population Age: In utero, Preterm newborn infants, Newborns, Under 18, Adults | Gender: Female | |
Trial protocol: SI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004380-20 | Sponsor Protocol Number: SP0986 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:Sanol GmbH | |||||||||||||
Full Title: A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulp... | |||||||||||||
Medical condition: Iron Deficiency Anemia | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004439-19 | Sponsor Protocol Number: 16/0099 | Start Date*: 2017-06-01 | |||||||||||
Sponsor Name:Alfred Health | |||||||||||||
Full Title: IV iron for Treatment of Anaemia before Cardiac Surgery | |||||||||||||
Medical condition: Anaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003265-36 | Sponsor Protocol Number: AG348-C-022 | Start Date*: 2022-05-10 | |||||||||||
Sponsor Name:Agios Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Subjects With Pyruvate Kinase Deficiency Who Are Regularly T... | |||||||||||||
Medical condition: Pyruvate Kinase Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) CZ (Ongoing) DK (Ongoing) IT (Prematurely Ended) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001855-15 | Sponsor Protocol Number: QBGJ398-203 | Start Date*: 2022-02-02 | |||||||||||
Sponsor Name:QED Therapeutics, Inc. | |||||||||||||
Full Title: Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children with Achondroplasia: PROPEL OLE | |||||||||||||
Medical condition: Achondroplasia in Children | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001252-52 | Sponsor Protocol Number: CZOL446H2337 | Start Date*: 2009-03-12 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo controlled efficacy and safety trial of intravenous zoledronic acid twice yearly compared to placebo in osteoporotic children treated with glucocort... | |||||||||||||
Medical condition: Treatment of osteoporosis in a paediatric population (aged 5 to 17 years old) treated with systemic glucocorticoids (i.v. or oral) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) FI (Prematurely Ended) BE (Completed) DE (Prematurely Ended) PL (Prematurely Ended) Outside EU/EEA HU (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001827-11 | Sponsor Protocol Number: VX19-445-107 | Start Date*: 2020-04-24 | |||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | |||||||||||||
Full Title: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445/TEZ/IVA Combination Therapy in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) IE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.